Long-Term Outcomes of Inoperable Patients with Aortic Stenosis Randomized to Transcatheter Aortic Valve Replacement or Standard Therapy
نویسندگان
چکیده
Cleveland Clinic Foundation, Cleveland, OH; Cedars Sinai Medical Center, Los Angeles, CA; Columbia University Medical Center/ New York Presbyterian Hospital, New York, NY; Lenox Hill Hospital, New York, NY; St. Paul’s Hospital, Vancouver, BC, Canada; Baylor Healthcare System, Plano, TX; Emory University School of Medicine, Atlanta, GA; Hospital of the University of Pennsylvania, Philadelphia, PA; Medstar Washington Hospital Center, Washington, DC; Edwards Lifesciences, Irvine, CA; Stanford University, Stanford, CA
منابع مشابه
Response to Letter Regarding Article, "Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy".
BACKGROUND The long-term outcomes of transcatheter aortic valve replacement (TAVR) in inoperable patients with severe aortic stenosis remain unknown. METHODS AND RESULTS In the Placement of Aortic Transcatheter Valves (PARTNER) study, 358 patients were randomly assigned to TAVR or standard therapy. We report the 3-year outcomes on these patients, and the pooled outcomes for all randomly assig...
متن کاملTranscatheter Aortic Valve Replacement: A Review Article
Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...
متن کاملNew Drugs and Technologies Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIENTM Transcatheter Heart Valve
Transcatheter aortic valve replacement (TAVR) has been developed as a novel approach for the treatment of high-risk patients with aortic stenosis (AS). Although surgical aortic valve replacement is the standard of care for patients with symptomatic AS, it is associated with poor outcome when applied to patients with extreme operative risk. This subset of patients is usually deferred from surger...
متن کاملCost-effectiveness of transcatheter aortic valve replacement.
Patients with symptomatic aortic stenosis have a poor prognosis, and medical therapy has little, if any, effect on their natural history. Surgical aortic valve replacement (AVR) is risky, yet it appears to be effective in extending life expectancy and reducing symptoms due to aortic stenosis. In this setting, the development of transcatheter AVR appears to be a breakthrough technology, potentia...
متن کاملCurrent status of transcatheter aortic valve replacement.
The advent of transcatheter aortic valve replacement (TAVR) has modified the treatment of severe aortic stenosis (AS). Large randomized trials and multicenter registries have endorsed the efficacy of TAVR in improving outcomes in patients with severe AS who are inoperable or high surgical risk. There has been a noticeable shift in using TAVR in patients with AS who are not at a high surgical ri...
متن کامل[Progress in transcatheter aortic valve implantation].
In 2002, the first patient underwent transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis. There followed several single-center trials which demonstrated that this new approach was feasible for the treatment of patients who were inoperable or at a very high risk with standard surgical aortic valve replacement. The results of recent multicenter trials u...
متن کامل